Janssen v. Celltrion: CAFC & District Court Litigation Update
By EsqSocial Corporation 29/08/17
As we previously reported last year, in the ongoing Janssen v. Celltrion litigation concerning Celltrion’s Inflectra®, a biosimilar of Janssen’s Remicade® (infliximab), Janssen appealed the district court’s partial final judgment of invalidity of...
By: Goodwin